6th Annual Metabolic Diseases Drug Discovery & Development World Summit

Venue: Hyatt Regency La Jolla at Aventine

Location: San Diego, California, United States

Event Date/Time: Jul 16, 2007 End Date/Time: Jul 17, 2007
Early Registration Date: Jun 29, 2007
Report as Spam

Description

This year's conference continues a tradition of bringing together some of the most exciting New Target areas and Early Drug Candidates to treat Metabolic Diseases. This year's conference will include informative updates on small molecule compounds currently in clinical trials from the DPP-IV inhibitor and GK activators classes. SCD-1 and ACC inhibitors as well as SIRT1 activators will also be reviewed. Nontraditional approaches to therapeutics including Gherlin Speigelmers and SGLT antisense therapeutics as well as traditional biologics such as PYY and Byetta will also be discussed. In addition we will examine New Target space in nutrient sensing, ceramides as well as animal models.

Venue

Additional Information

Speakers Include: Scott A. Summers, Ph.D. (Associate Professor of Biochemistry & Medicine, UNIVERSITY OF UTAH) - Keynote Address: The Role of Ceramides in Insulin Resistance and Metabolic Disease Ira Goldberg, M.D. (Professor of Medicine, COLUMBIA UNIVERSITY) - Keynote Address: Fatty Tissues: "Getting it in and Storing it Up" Stephen W. Kaldor, Ph.D. (President and CSO, TAKEDA SAND DIEGO, INC) Andrew D. Howard, Ph.D. (Distinguished Senior Investigator, MERCK RESEARCH LABORATORIES, METABOLIC DISORDERS-DIABETES) Kenneth Walsh, Ph.D. (Professor of Medicine & Head, Molecular Cardiology, Whitaker BOSTON UNIVERSITY SCHOOL OF MEDICINE) Andrew Siwkowski, MS.c. (Director, EXPLORATORY DRUG DISCOVERY ISIS PHARMACEUTICALS, INC.) Mads Tang-Christensen, M.D., Ph.D. (Director of Contract Research, RHEOSCIENCE A/S) Sotirios K. Karathanasis, Ph.D. (Sr. Research Fellow, Endocrine and Cardiovascular Research & Adjunct Professor, Department of Medicine, ELI LILLY AND INDIANA UNIVERSITY PURDUE UNIVERSITY) Tony K.T. Lam, Ph.D. (John Kitson McIvor Chair in Diabetes Research & Assistant professor of Physiology and Medicine, TORONTO GENERAL HOSPITAL & UNIVERSITY OF TORONTO) Preeti Kishore, M.D. (Assistant Professor of Medicine, ALBERT EINSTEIN COLLEGE OF MEDICINE) Daniel Howey, M.D. (Medical Fellow, Exploratory Medicine, ELI LILLY AND COMPANY) Diane Tribble, Ph.D. (ISIS PHARMACEUTICALS, INC.) Brett Monia, Ph.D. (Vice President of Antisense Drug Discovery, ISIS PHARMACEUTICALS, INC.) Michael Jirousek, Ph.D. (Senior Vice President of Research, SIRTRIS PHARMACEUTICALS, INC.) Jill Milne, Ph.D. (Senior Director of Biology, SIRTRIS PHARMACEUTICALS, INC.) Mausumee Guha, Ph.D. (KALPSYS) Brian K. Hubbard, Ph.D. (NOVARTIS INSTITUTE FOR BIOMEDICAL RESEARCH) H.James Harwood Jr., Ph.D. (Principal Research Investigator, PFIZER GLOBAL RESEARCH & DEVELOPMENT) Rebecca Taub, M.D. (Vice President Research, Metabolic Diseases, ROCHE) Cristina M. Rondinone, Ph.D. (Director Research Metabolic Diseases, HOFFMANN-LA ROCHE INC.) Francesco Rubino, M.D. (Assistant Professor of Surgery, CATHOLIC UNIVERSITY OF ROME ITALY) Michael Hanley, Ph.D. (AMYLIN PHARMACEUTICALS) David Maggs, M.D. (Vice President, Medical Affairs, AMYLIN PHARMACEUTICALS) Peter S. DiStefano, Ph.D. (Chief Scientific Officer, ELIXIR PHARMACEUTICALS) David L. Linemeyer, Ph.D. (Executive Director, METABSIS THERAPEU